Literature DB >> 30518440

Objectively Measured Disrupted Sleep Is Independently and Directly Associated With Low Exercise Capacity in Males: A Structural Equation Model.

Ren-Jing Huang1, Shin-Da Lee2,3,4, Ching-Hsiang Lai5, Shen-Wen Chang6, Ai-Hui Chung6, Chiung-Wei Chen7, I-Ning Huang7, Hua Ting6,7,8.   

Abstract

STUDY
OBJECTIVES: We investigated the interaction between objective sleep disturbance and obesity, sedentary lifestyle, and lung dysfunction and whether it is negatively associated with cardiorespiratory fitness.
METHODS: In this community cohort study of 521 men (age 46.6 ± 7.5 years), measures of anthropometry, pulmonary function, overnight sleep polysomnography, and cardiopulmonary exercise testing were processed stepwise using structural equation modeling (SEM).
RESULTS: A univariate correlation analysis was used to group the corresponding variables (in parentheses) into the following eligible latent variables for lower exercise capacity: obesity (body mass index, waist-to-hip ratio), irregular exercise, impaired lung function (predicted values of forced expiratory volume in the first second, forced vital capacity, maximal ventilatory volume, and lung diffusion capacity for carbon monoxide), disrupted sleep (total sleep time, percentage of slow-wave sleep, sleep efficiency), and sleep-disordered breathing (apnea-hypopnea index, lowest oxygen saturation, percentage of total period of oxygen saturation < 90%). Advanced SEM analyses produced a well-fitted final confirmatory model that obesity (direct strength βd = .366, P < .001), irregular exercise (βd = .274, P < .001), and impaired lung function (βd = .152, P < .001), with their mutual interactions, as well as disrupted sleep (βd = .135, P = .001) were independently and directly associated with low exercise capacity. By contrast, sleep-disordered breathing (βd = 0, P = .215) was related to low exercise capacity indirectly through obesity into the mutual interaction cycle of obesity, irregular exercise, and impaired lung function. Sleep-disordered breathing was robustly and mutually correlated with obesity (mutual relationship index = .534, P < .001).
CONCLUSIONS: Objectively measured disrupted sleep is directly and independently associated with low exercise capacity; however, sleep-disordered breathing is indirectly mediated by obesity and mutual interactions among obesity, lung dysfunction, and sedentary lifestyle and is linked to low exercise capacity. Our findings indicate that individuals with limited exercise capacity without definite causes should undertake a sleep study, particularly in those describing symptoms of sleep-disordered breathing or insomnia.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  cardiorespiratory fitness; insomnia; lung function; physical activity

Mesh:

Year:  2018        PMID: 30518440      PMCID: PMC6287719          DOI: 10.5664/jcsm.7522

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  38 in total

1.  Effects of bilateral T2-sympathectomy on static and dynamic heart rate responses to exercise in hyperhidrosis patients.

Authors:  Hua Ting; Shin-Da Lee; Ai-Hui Chung; Ming-Lung Chuang; Gin-Den Chen; Jiuan-Miaw Liao; Chen-Lurng Chang; Thomas S M Chiou; Tzer-Bin Lin
Journal:  Auton Neurosci       Date:  2005-08-31       Impact factor: 3.145

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.

Authors:  M Wei; J B Kampert; C E Barlow; M Z Nichaman; L W Gibbons; R S Paffenbarger; S N Blair
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

4.  Self-reported sleep duration and time in bed as predictors of physical function decline: results from the InCHIANTI study.

Authors:  Sari Stenholm; Erkki Kronholm; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

5.  Lipotoxic heart disease in obese rats: implications for human obesity.

Authors:  Y T Zhou; P Grayburn; A Karim; M Shimabukuro; M Higa; D Baetens; L Orci; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Utility of childhood BMI in the prediction of adulthood disease: comparison of national and international references.

Authors:  Ian Janssen; Peter T Katzmarzyk; Sathanur R Srinivasan; Wei Chen; Robert M Malina; Claude Bouchard; Gerald S Berenson
Journal:  Obes Res       Date:  2005-06

7.  Post- to pre-overnight sleep systolic blood pressures are associated with sleep respiratory disturbance, pro-inflammatory state and metabolic situation in patients with sleep-disordered breathing.

Authors:  Hua Ting; Hsiao-Sui Lo; Shu-Yun Chang; Ai-Hui Chung; Pai-Chuan Kuan; Su-Chuan Yuan; Chien-Ning Huang; Shin-Da Lee
Journal:  Sleep Med       Date:  2008-10-25       Impact factor: 3.492

8.  Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome.

Authors:  D Sajkov; R J Cowie; A T Thornton; H A Espinoza; R D McEvoy
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

9.  Insomnia symptoms and cardiorespiratory fitness in healthy individuals: the Nord-Trøndelag Health Study (HUNT).

Authors:  Linn B Strand; Lars E Laugsand; Ulrik Wisløff; Bjarne M Nes; Lars Vatten; Imre Janszky
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

Review 10.  Practice parameters for using polysomnography to evaluate insomnia: an update.

Authors:  Michael Littner; Max Hirshkowitz; Milton Kramer; Sheldon Kapen; W McDowell Anderson; Dennis Bailey; Richard B Berry; David Davila; Stephen Johnson; Clete Kushida; Daniel I Loube; Merrill Wise; B Tucker Woodson
Journal:  Sleep       Date:  2003-09       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.